Under-the-radar drug stock has big rebound potential here despite turmoil, says Carter Worth
Carter breaks down the charts on large-cap pharmaceutical manufacturer AbbVie.…
154,100€
-0,77%
Echtzeit-Aktienkurs ABBVIE
Bid:
Ask:
Nachrichten zur ABBVIE Aktie
The Last Time the Stock Market Started a Year This Badly Was 2022. Is Another Crash Coming?
As of Mondays close, the S&P 500 has fallen by about 15% this year (although the index regained about half…
Stocks making the biggest moves midday: Apple, Tesla, AbbVie, Delta Air Lines and more
These are the stocks posting the largest moves in midday trading.…
2 Top Dividend Stocks That Could Set You Up for Life
With equity markets in shambles due to President Donald Trumps trade policies, now might be as good a time as…
Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Heres What Retirees Need to Know So Far.
From TV star to powerful government official. Thats the path taken by President Donald Trump and his new administrator of…
Is Vertex Pharmaceuticals Stock a Buy?
Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex…
3 Dividend Stocks to Buy and Hold for the Next Decade
What should investors do when stocks are tanking over the short term? Probably the best answer is to think long…
2 Dividend Stocks to Buy Hand Over Fist in April
One factor that keeps some investors away from healthcare stocks is the sectors dearth of generous and reliable dividend payers.…
AbbVie (ABBV) Stock Moves -1.73%: What You Should Know
In the closing of the recent trading day, AbbVie (ABBV) stood at $201.64, denoting a -1.73% change from the preceding…
AbbVie cuts 2025 profit forecast on acquisition expenses By Reuters
AbbVie cuts 2025 profit forecast on acquisition expenses…
AbbVie cuts 2025 profit forecast on acquisition expenses
AbbVie on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition-related expenses.…
3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About
"Buy and hold" is a simple strategy for investors, but it can be a hard one to stick to in…
AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?
Those who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks…
Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis
Basel, March 31, 2025 – Novartis announced today the appointment of Karen Hale to the expanded role of Chief Legal…
3 Relatively Safe Stocks to Buy Right Now
Investing in stocks comes with risks. Theres no way around that fact. However, some stocks can be less risky than…
5 Large Drug Stocks to Watch as Industry Recovers
R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo…
AbbVie (ABBV) Stock Sinks As Market Gains: Heres Why
The latest trading day saw AbbVie (ABBV) settling at $209.17, representing a -0.4% change from its previous close.…
AbbVie Aktie: Erneut auf Expansionskurs!
Der Pharmakonzern diversifiziert sein Portfolio mit einem Milliarden-Deal für neuartige Gewichtsreduktionsmittel und stärkt gleichzeitig seine Position in der Onkologie. AbbVie…
Heres How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends
So, you want to invest in AbbVie (NYSE: ABBV) because its a promising dividend-paying stock, and you also want to…
S&P 500 Sell-Off: Heres Why This ETF May Be the Smartest Way to Invest in the S&P 500 Right Now
The Sun was shining brightly on the U.S. stock market over the past couple of years. Unfortunately, some clouds have…
3 Dividend Stocks to Buy for Reliable Passive Income
Youll need passive income to live well in retirement, especially with Social Securitys uncertain future. The Office of Retirement and…
AbbVie (ABBV) Stock Moves -0.29%: What You Should Know
AbbVie (ABBV) closed the most recent trading day at $213.85, moving -0.29% from the previous trading session.…
5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond
Lets say you have some money in your pocket you want to invest, but youre not sure where to put…
The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands
AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands are included in this Analyst Blog.…
1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction
Stock market sell-offs are often great opportunities to buy dividend stocks. Thats because dividend yields move in the opposite direction…
Top Analyst Reports for AbbVie, Lockheed Martin & Dell
Todays Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin Corporation (LMT) and…
S&P 500 Index Funds Yield Just 1.3%. Consider Buying These 2 Low-Cost Vanguard ETFs to Generate More Passive Income.
The heaviest weighted components of the S&P 500 are companies like Apple, Microsoft, and Nvidia -- tech leaders that tend…
Top Analyst Reports for AbbVie, Lockheed Martin & Dell
Todays Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin Corporation (LMT) and…